Home Page
Doctors
Professor Doctor

Celaletdin CAMCI

Medical Oncology
Resume
MEMBERSHIPS
SCIENTIFIC PUBLICATIONS
  • EDUCATION
    • Atatürk Üniversitesi Tıp Fakültesi
    • Ankara Numune Eğitim ve Araştırma Hastanesi İç Hastalıkları
  • WORK EXPERIENCE
    • Bakırköy Ethica İncirli Hastanesi/ İç Hastalıkları ve Tıbbi Onkoloji Uzmanı
    • Gaziantep Üniversitesi Tıp Fakültesi/İç Hastalıkları ve Tıbbi Onkoloji Uzmanı
    • Aydın Adnan Menderes Üniversitesi Tıp Fakültesi/İç Hastalıkları ve Tıbbi Onkoloji Uzmanı
    • Çukurova Üniversitesi Tıp Fakültesi/Tıbbi Onkoloji Yan Dal Uzmanlık öğrencisi
    • Aydın Adnan Menderes Üniversitesi Tıp Fakültesi/İç Hastalıkları Uzmanı
    • Ankara Numune Eğitim ve Araştırma Hastanesi/İç Hastalıkları Uzmanlık öğrencisi
  • MEMBERSHIPS
    • Türk Tıbbi Onkoloji Derneği
    • ESMO (European Society of Medical Oncology)
    • ASCO (American Society of Medical Oncology)
  • SCIENTIFIC PUBLICATIONS
    • Yıldırım İH, Çakmak EA, Camci C. Gene expression of ING4 gene in pancreatic cancers and splice forms of ING4 gene.


      Cell Mol Biol (Noisy-le-grand). 2018 Oct 30;64(13):6-9.
    • Aktas G, Kus T, Kalender ME, Bakir K, Camci C. A patient with organizing pneumoniadevelopment during the use of Capecitabine maintenance treatment for gastric cancer.


      Respir Case Rep 2016;5(1):10-14. doi: 10.5505/respircase.2016.32559
    • Kus T, Aktas G, Kalender ME, Sevinc A, Camci C. Comparison of FOLFIRINOXChemotherapy with Other Regimens in Patients with Biliary Tract Cancer: RetrospectiveStudy. J Gastrointest Cancer. Journal of


      gastrointestinal cancer June 2017; 48 (2), 170-175. doi:10.1007/s12029-016-9880-y
    • Kus T, Aktas G, Sevinc A, Oktay C, Kalender ME, Camci C. Tyrosine kinase inhibitors improve parenchymal findings of liver cirrhosis in a patient exhibiting concomitant hepatocellular carcinoma and renal cell cancer.


      Molecular and Clin Oncol 2016: 290-292. doi: 10.3892/mco.2015.677.
    • Aktas G, Kus T, Kalender ME, Kervancioglu S, Sevinc A, Kul S, Camci C. Sorafenib with TACE improves the survival of hepatocellular carcinoma patients with more than 10 cm tumor:


      a single-center retrospective study J BUON 22 (1), 150-56.
    • Suner A, Buyukhatipoglu H, Aktas G, Kus T, Ulasli M, Oztuzcu S, Kalender ME, Sevinc A, Kul S, Camci C.Polymorphisms in the MTHFR gene are associated with recurrence risk in lymph node-positive breast cancer patients.


      Onco Targets Ther. 2016 Sep 9;9:5603-9. doi: 10.2147/OTT.S104890.
    • Kus T, Aktas G, Kalender ME, Demiryurek AT, Ulasli M, Oztuzcu S, Sevinc A, Kul S, Camci C. Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel.


      Onco Targets Ther. 2016 Aug 12;9:5073-80. doi: 10.2147/OTT.S106574.
    • Aktas G, Kus T, Kalender ME, Sevinc A, Camci C, Kul S. Survival analysis in second-line and third-line chemotherapy with irinotecan followed by topotecan or topotecan followed by irinotecan for extensive-stage small-cell lung cancer patients: a single-center retrospective study.


      Onco Targets Ther. 2016 Apr 1;9:1921-6. doi: 10.2147/OTT.S101390.
    • Igci M, Kalender ME, Borazan E, Bozgeyik I, Bayraktar R, Bozgeyik E, Camci C, Arslan A. High-throughput screening of Sirtuin family of genes in breast cancer.


      Gene. 2016 Jul 15;586(1):123-8. doi: 10.1016/j.gene.2016.04.023.
    • Kus T, Aktas G, Kalender ME, Sari I, Ulker E, Camci C. Collision tumor consisting of primary follicular lymphoma and adenocarcinoma in the cecum: A case report and literatüre review.


      Oncol Lett. 2016 Apr;11(4):2801-2805. doi:10.3892/ol.2016.4310.
    • Kus T, Aktas G, Sevinc A, Oktay C, Kalender ME, Camci C. Tyrosine kinase inhibitors improve parenchymal findings of liver cirrhosis in a patient exhibiting concomitant hepatocellular carcinoma and renal cell cancer.


      Mol Clin Oncol. 2016 Feb;4(2):290-292. Epub 2015 Nov 13.
    • Kus T, Aktas G, Kalender ME, Tutar E, Ulker E, Camci C. Complete response of a recurrent- metastatic liposarcoma with dedifferentiated histological features following the administration of trabectedin and review of literature.


      J Cancer Res Ther. 2015 Oct- Dec;11(4):974-6. doi: 10.4103/0973-1482.158032.
    • Kus T, Aktas G, Sevinc A, Kalender ME, Yilmaz M, Kul S, Oztuzcu S, Oktay C, Camci C. Prognostic impact of initial maximum standardized uptake value of (18)F-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib.


      Onco Targets Ther. 2015 Dec 15;8: 3749-56. doi: 10.2147/OTT.S94945
    • Kus T, Aktas G, Alpak G, Kalender ME, Sevinc A, Kul S, Temizer M, Camci C. Efficacy of venlafaxine for the relief of taxane and oxaliplatin-induced acute neurotoxicity: a single- center retrospective case-control study.


      Support Care Cancer. 2015. [Epub ahead of print]
    • Kus T, Aktas G, Sevinc A, Oktay C, Kalender ME, Camci C. Tyrosine kinase inhibitors improve parenchymal findings of liver cirrhosis in a patient exhibiting concomitant hepatocellular carcinoma and renal cell cancer.


      Molecular and Clinical Oncology 2015. doi: 10.3892/mco.2015.677.
    • Kus T, Aktas G, Sevinc A, Kalender ME, Yilmaz M, Kul S, Oztuzcu S, Oktay C, Camci C. Prognostic impact of initial maximum standardized uptake value of 18F-FDGPET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib.


      OncoTargets and Therapy 2015:8 1–8.
    • Comez G, Goktepe MF, Oztuzcu S, Sevinc A, Camci C. The isolated extranodal relapse of the isolated extranodal non- Hodgkin lymphoma:


      A case report. J Cancer Res Ther. 2015 Jul-Sep;11(3):645.
    • Kus T, Aktas G, Kalender ME, Sevinc A, Kul S, Suner A, Ulker E, Camci C. Taxane-induced peripheral sensorial neuropathy in cancer patients is associated with duration of diabetes mellitus: a single-center retrospective study. Support Care Cancer.


      2015 Aug 18. [Epub ahead of print]
    • Kus T, Aktas G, Sevinc A, Kalender ME, Camci C. Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?


      Onco Targets Ther. 2015 Jun 5;8:1341-3.
    • Alptekin M, Eroglu S, Tutar E, Sencan S, Geyik MA, Ulasli M, Demiryurek AT, Camci C. Gene expressions of TRP channels in glioblastoma multiforme and relation with survival.Tumour Biol.


      2015 Dec;36(12):9209-13. doi: 10.1007/ s13277-015-3577-x.
    • Aykan NF, Yalçın S, Turhal NS, Özdoğan M, Demir G, Özkan M, Yaren A, Camcı C, Akbulut H, Artaç M, Meydan N, Uygun K, Işıkdoğan A, Ünsal D, Özyılkan Ö, Arıcan A, Seyrek E, Tekin SB, Manavoğlu O, Özet A, Elkıran T, Dişçi R. Epidemiology of colorectal cancer in Turkey: A cross-sectional disease registry study (A Turkish Oncology Group trial).


      Turk J Gastroenterol. 2015 Mar;26(2):145-53.
    • Kus T, Kalender ME, Aktas G, Suner A, Camci C. Atypical presentation of disseminated intravascular coagulation with synchronous peripheral venous thromboembolism and arterial gangrene in a pancreatic cancer patient: a case report.


      JOP. 2015 Mar 20;16(2):195-7.
    • Kalender ME, Buyukhatipoglu H, Balakan O, Suner A, Dirier A, Sevinc A, Bulbul F, Tatli AM, Ulas T, Camci C. Depression, anxiety and quality of life through the use of complementary and alternative medicine among breast cancer patients in Turkey.


      J Cancer Res Ther. 2014 Oct-Dec;10(4):962-6.
    • Ergün S, Ulasli M, Igci YZ, Igci M, Kırkbes S, Borazan E, Balik A, Yumrutaş O, Camci C, Cakmak EA, Arslan A, Oztuzcu S. The association of the expression of miR-122-5p and its target ADAM10 with human breast cancer.


      Mol Biol Rep. 2015 Feb;42(2):497-505. doi: 10.1007/s11033-014-3793-2. Epub 2014 Oct 16.
    • Balakan O, Kalender ME, Suner A, Cengiz B, Oztuzcu S, Bayraktar R, Borazan E, Babacan T, Camci C. The relationship between urotensin II and its receptor and the clinicopathological parameters of breast cancer.


      Med Sci Monit. 2014 Aug 12;20:1419-25.
    • Gogebakan B, Bayraktar R, Suner A, Balakan O, Ulasli M, Izmirli M, Oztuzcu S, Camci C. Do fasudil and Y-27632 affect the level of transient receptor potential (TRP) gene expressions in breast cancer cell lines?


      Tumour Biol. 2014 Aug;35(8):8033-41.
    • Suner A, Buyukhatipoglu H, Balakan O, Kalender ME, Ulas T, Sevinc A, Camci C. Importance of HER2 Work-Up and Treatment Even in Patients with Poor Performance Status: A Case Report.


      Case Rep Oncol Med. 2014;2014:731581
    • Arican A, Bozkurt T, Bozcuk H, Demirkan B, Buyukberber S, Alkis N, Sanli UA, Camci C, Yildiz M, Yucel I, Uygun K, Aslay I, Demiray M, Bese NS, Isikdogan A, Bahat Z, Gemici C, Ozdemir F, Ozdener F, Pekin B. A cross-sectional survey of the diagnosis and management of bone metastasis in breast cancer patients in Turkey.


      Support Care Cancer. 2014 Oct;22(10):2629-34.
    • Yalcin S, Uslu R, Dane F, Yilmaz U, Zengin N, Buyukunal E, Buyukberber S, Camci C, Sencan O, Kilickap S, Ozdener F, Cevik D. Bevacizumab + capecitabine as maintenance therapy after initial bevacizumab + XELOX treatment in previously untreated patients with metastatic colorectal cancer: phase III 'Stop and Go' study results–a Turkish Oncology Group Trial.


      Oncology. 2013;85(6):328-35.
    • Işık AF, Sanlı M, Yılmaz M, Meteroğlu F, Dikensoy O, Sevinç A, Camcı C, Tunçözgür B, Elbeyli L. Intrapleural hyperthermic perfusion chemotherapy in subjects with metastatic pleural malignancies.


      Respir Med. 2013 May;107(5):762-7.
    • Erkutlu I, Cigiloglu A, Kalender ME, Alptekin M, Demiryurek AT, Suner A, Ozkaya E, Ulasli M, Camci C. Correlation between Rho-kinase pathway gene expressions and development and progression of glioblastoma multiforme.


      Tumour Biol. 2013 Apr;34(2):1139-44.
    • Sari I, Berberoglu B, Ozkara E, Oztuzcu S, Camci C, Demiryurek AT. Role of rho-kinase gene polymorphisms and protein expressions in colorectal cancer development.


      Pathobiology. 2013;80(3):138-45.
    • Erkutlu I, Cigiloglu A, Kalender ME, Alptekin M, Demiryurek AT, Suner A, Ozkaya E, Ulasli M, Camci C. Correlation between Rho-kinase pathway gene expressions and development and progression of glioblastoma multiforme.


      Tumour Biol. 2013 Apr;34(2):1139-44.
    • Sari I, Berberoglu B, Ozkara E, Oztuzcu S, Camci C, Demiryurek AT. Role of rho-kinase gene polymorphisms and protein expressions in colorectal cancer development.


      Pathobiology. 2013;80(3):138-45.
    • Seker M, Sevinc A, Yildiz R, Cihan S, Kaplan MA, Gokdurnali A, Dane F, Yaman E, Karaca H, Colak D, Uyeturk U, Bilici A, Ozdemir NY, Kalender ME, Uncu D, Salepci T, Isikdogan A, Benekli M, Ozkan M, Gumus M, Coskun U, Camci C, Oksuzoglu B, Buyukberber S; Anatolian Society of Medical Oncology (ASMO). Prognostic factors in gastrointestinal stromal tumors: multicenter experience of 333 cases from Turkey.


      Hepatogastroenterology. 2013 Jun;60(124):768-75.
    • Igci M, Cakmak EA, Oztuzcu S, Bayram A, Arslan A, Gogebakan B, Igci YZ, Cengiz B, Ozkara E, Camci C, Demiryurek AT. Mutational screening of the SOCS3 gene promoter in metastatic colorectal cancer patients.


      Genet Test Mol Biomarkers. 2012 Dec;16(12):1395- 400.
    • Kaya AO, Coskun U, Ozkan M, Sevinc A, Yilmaz AU, Gumus M, Unal OU, Ozdemir NY, Alici S, Berk V, Degerli H, Oner MK, Ozturk C, Kefeli U, Camcı C; Anatolian Society of Medical Oncology (ASMO). Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy.


      Onkologie. 2012;35(10):576-80.
    • Oguz E, Alasehirli B, Pehlivan Y, Onat AM, Oztuzcu S, Ozkara E, Kisacik B, Camci C, Demiryürek AT. Association between Rho-kinase (ROCK2) gene polymorphisms and Behçet's disease.


      Transl Res. 2012 Dec;160(6):428-34.
    • Altinbas M, Kalender ME, Oven B, Sevinc A, Karaca H, Kaplan MA, Alici S, Arpaci E, Yildiz R, Uncu D, Camci C, Gumus M. Weekly topotecan for recurrent small cell lung cancer – a retrospective Anatolian Medical Oncology Group study.


      Asian Pac J Cancer Prev. 2012;13(6):2909-12.
    • Kaya AO, Büyükberber S, Ozkan M, Alkiş N, Sevinc A, Ozdemir NY, Alici S, Esbah O, Berk V, Camci C, Ulas A, Coskun U, Benekli M; Anatolian Society of Medical Oncology (ASMO). Efficacy and toxicity of gemcitabine plus docetaxel combination as a second line therapy for atients with advanced stage soft tissue sarcoma.


      .Asian Pac J Cancer Prev. 2012;13(2):463-7.
    • Turk HM, Camci C, Sevinc A, Bukyukberber S, Sari I, Adli M. Cyclooxygenase-2 expression is ot a marker of poor survival in lung cancer.


      Asian Pac J Cancer Prev. 2012;13(1):315-8.
    • Freedman JE, Ercan B, Morin KM, Liu CT, Tamer L, Ayaz L, Kanadasi M, Cicek D, Seyhan AI, Akilli RE, Camci C, Cengiz B, Oztuzcu S, Tanriverdi K.The distribution of circulating microRNA and their relation to coronary disease.


      F1000Res. 2012 Nov 19;1:50.
    • Camci C, Sahin A, Sevinc A, Kalender ME, Oztuzcu S, Sever ON, Ozkara E, Demiryürek AT. Peripheral blood guanylyl cyclase c (GCC) expressions are associated with prognostic parameters and response to therapy in colorectal cancer patients.


      Tumour Biol. 2011 Dec;32(6):1265-70.
    • Turkbeyler IH, Pehlivan Y, Comez G, Pehlivan D, Sevinc A, Kalender ME, Karakok M, Camci C. Esophagus cancer and IgA deficiency in a patient with Dubowitz syndrome: a case report.


      Tokai J Exp Clin Med. 2011 Jul 20;36(2):29-30.
    • Pehlivan Y, Sevinc A, Turkbeyler IH, Dirier A, Kalender ME, Camci C. Another cause of pancytopenia in a patient receiving temozolomide.


      Med Princ Pract. 2011;20(4):377-9.
    • Pehlivan S, Ovayolu O, Ovayolu N, Sevinc A, Camci C. Relationship between hopelessness, loneliness, and perceived social support from family in Turkish patients with cancer.


      Support Care Cancer. 2012 Apr;20(4):733-9.
    • Comez G, Sevinc A, Sever ON, Babacan T, Sarı I, Camci C. An unusual case of aplastic anemia caused by temozolomide.


      Case Rep Med. 2010;2010:975039. doi: 10.1155/2010/975039.
    • Sevinc A, Camci C, Sari I, Kalender ME, Er O, Soyuer I, Dikilitas M, Yilmaz U, Sagol O, Alacacioglu A. Cyclooxygenase-2 expression in gastrointestinal stromal tumours.


      Asian Pac J Cancer Prev. 2010;11(4):849-53.
    • Demiryurek AT, Erbagci I, Oztuzcu S, Alasehirli B, Ozkara E, Seker M, Sönmez A, Ozsan M, Camci C. Lack of association between the Thr431Asn and Arg83Lys polymorphisms of the ROCK2 gene and diabetic retinopathy.


      Curr Eye Res. 2010 Dec;35(12):1128-34.
    • Kalender ME, Demiryürek S, Oztuzcu S, Kizilyer A, Demiryürek AT, Sevinc A, Dikilitas M, Yildiz R,Camci C. Association between the Thr431Asn polymorphism of the ROCK2 gene and risk of developing metastases of breast cancer.


      Oncol Res. 2010;18(11-12):583-91.
    • Smith IE, Pierga JY, Biganzoli L, Cortés-Funes H, Thomssen C, Pivot X, Fabi A, Xu B, Stroyakovskiy D, Franke FA, Kaufman B, Mainwaring P, Pienkowski T, De Valk B, Kwong A, González-Trujillo JL, Koza I, Petrakova K, Pereira D, Pritchard KI; ATHENA Study Group. First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients.


      Ann Oncol. 2011 Mar;22(3):595-602.
    • Kalender ME, Comez G, Sevinc A, Dirier A, Camci C. Leech therapy for symptomatic relief of cancer pain.


      Pain Med. 2010 Mar;11(3):443-5.
    • Kalender ME, Camci C, Sevinc A. Limited efficacy of Cisplatin, UFT and Hydroxyurea treatment in a retrospective evaluation of patients with metastatic gastric cancer.


      Asian Pacific J Cancer Prev. 2009; 10: 795-798.
    • Yildiz R, Kalender ME, Dane F, Sevinc A, Gumus M, Camci C, Alici S, Kaya AO, Yaman E, Ozturk B, Coskun U, Benekli M, Uncu D, Buyukberber S. Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens.


      J Oncol Pharm Pract. 2010 Sep;16(3):173-8.
    • Arikan-Sengul C, Pehlivan Y, Sevinc A, Karakok M, Kalender ME, Camci C. A Case of Metachronous Triple Primary Urogenital Cancer: Urinary Bladder, Prostate, and Renal Cancer.


      Onkologie 2009;32:122–124.
    • Coskun U, Alkis N, Celenkoglu G, Buyukberber S, Ozkan M, Camci C, Uner A, Er O, Aslan UY, Sevinc A, Tokluoglu S, Ozturk B, Yildiz R, Benekli M; Anatolian Society of Medical Oncology. Gemcitabine combined with uracil-tegafur in patients with advanced pancreatic cancer.


      J Natl Med Assoc. 2009 Aug;101(8):761-4.
    • Buyukberber N, Buyukberber S, Sevinc A, Camci C. Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients.


      Med Oncol. 2009;26(1):55-61.
    • Helvaci MR, Sevinc A, Camci C, Yalcin A.Treatment of white coat hypertension with metformin.


      Int Heart J. 2008 Nov;49(6):671-9.
    • Alacacioglu A, Somali I, Simsek I, Astarcioglu I, Ozkan M, Camci C, Alkis N, Karaoglu A, Tarhan O, Unek T, Yilmaz U. Epidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter study.


      Jpn J Clin Oncol. 2008 Oct;38(10):683-8.
    • Kalender ME, Sevinc A, Yilmaz M, Ozsarac C, Camci C.Detection of complete response to imatinib mesylate (Glivec((R))/Gleevec ((R))) with 18F-FDG PET/CT for low-grade endometrial stromal sarcoma.


      Cancer Chemother Pharmacol. 2008 Jul 8.
    • Camci C, Sevinc A, Aslan Y, Kalender ME, Buyukberber S.Complete remission of platinium refractory ovarian cancer with second line tegafur with uracil monotherapy: a case report.


      Cancer Chemother Pharmacol. 2008 May 27.
    • Dane F, Turk HM, Sevinc A, Buyukberber S, Camci C, Tarakcioglu M.Markers of bone turnover in patients with lung cancer.


      J Natl Med Assoc. 2008 Apr;100(4):425-8.
    • Adaletli I, Camci C, Sevinc A, Urger E, Ozer H, Sari I. Isolated bone marrow natural killer cell lymphoma with central nervous system involvement mimicking a cerebral infarct.


      Oncologie. 2008 Mar;31(3):115-7. Epub 2008 Feb 8.
    • Benekli M, Yildiz R, Uner A, Er O, Yamac D, Alkis N, Coskun U, Camci C, Buyukberber S. Gemcitabine plus Capecitabine Combination in Metastatic Breast Cancer Patients Previously Treated with Anthracyclines and Taxanes.


      Oncology. 2008 Jan 14;72(5-6):308-313
    • Kalender ME, Sevinc A, Camci C, Turk HM, Karakok M, Akgul B.Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer.


      Oncology. 2007;73(5-6):415-8.
    • Comez G, Pehlivan Y, Kalender ME, Sevinc A, Sari I, Camci C. Synchronous Hodgkin’s disease and gastric adenocarcinoma.


      Oncology. 2007;73(5-6):422-5.
    • Sevinc A, Camci C, Yilmaz M, Buyukhatipoglu H.The diagnosis of C-kit negative GIST by PDGFRA staining: clinical, pathological, and nuclear medicine perspective.


      Onkologie.2007 Dec;30(12):645-8.
    • Sevinc A, Adli M, Kalender ME, Camci C.Benign causes of increased serum CA-125 concentration.


      Lancet Oncol. 2007 Dec;8(12):1054-5
    • Buyukberber S, Sari I, Camci C, Buyukberber NM, Sevinc A, Turk HM. Adrenomedullin expression does not correlate with survival in lung cancer.


      Med Oncol. 2007;24(2):245-9
    • Kalender ME, Sevinc A, Tutar E, Sirikci A, Camci C. Effect of sunitinib on metastatic gastrointestinal stromal tumor in patients with neurofibromatosis type 1: a case report.


      World J Gastroenterol. 2007 May 14;13(18):2629-32.
    • Zincirkeser S, Sevinc A, Kalender ME, Camci C. Early detection of response to imatinib therapy for gastrointestinal stromal tumor by using 18F-FDG-positron emission tomography and computed tomography imaging.


      World J Gastroenterol. 2007 Apr 21;13(15):2261-2.
    • Buyukhatipoglu H, Sevinc A, Pehlivan Y, Camci C.Is prophylactic cranial irradiation a possible option for human epidermal growth factor receptor 2-positive breast cancer?


      J Clin Oncol. 2007 Apr 1;25(10):1292
    • Buyukhatipoglu H, Sevinc A, Camci C, Buyukberber S, Sari I. case representing coexistence of acute myeloblastic leukemia and dedifferentiated liposarcoma: the possible role of chemotherapy in triggering dedifferentiation.


      Clin Lab Haematol. 2006 Oct;28(5):343-6.
    • Yilmaz M, Camci C, Sari I, Okan V, Sevinc A, Onat AM, Büyükhatipoglu H. Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto's disease) mimicking systemic lupus erythematosus: a review of two cases.


      Lupus. 2006; 15(6): 384-7.
    • Pehlivan Y, Sevinc A, Sari I, Gulsen MT, Buyukberber M, Kalender ME, Camci C. An interesting cause of esophageal ulcer etiology: Multiple myeloma of IgG kappa subtype.


      World J Gastroenterol. 2006 Apr 14; 12(14):2305-7.
    • Buyukberber M, Sevinc A, Cagliyan CE, Gulsen MT, Sari I, Camci C. Non-Hodgkin lymphoma with high adenosine deaminase levels mimicking peritoneal tuberculosis: An unusual presentation.


      Leuk Lymphoma. 2006 Mar;47(3):565-8.
    • Cetin M, Buyukberber S, Demir M, Sari I, Sari I, Deniz K, Eser B, Altuntas F, Camci C, Ozturk A, Turgut B, Vural O, Unal A. Overexpression of cyclooxygenase-2 in multiple myeloma: Association with reduced survival.


      Am J Hematol. 2005 Nov;80(3):169-173.
    • Yasa MH, Bektas A, Yukselen V, Akbulut H, Camci C, Ormeci N. DNA analysis and DNA ploidy in gastric cancer and gastric precancerous lesions.


      International Journal of Clinical Practice Volume 59 Issue 9 Page 1029 – September 2005.
    • Sevinc A, Camci C, Buyukberber S. Time is up! Acta Clin Belg. 2005 Mar-Apr; 60(2):106-7. Karaca M, Sevinc A, Aydin A, Gocmen A, Buyukberber S, Camci C, Sari I. Female adnexal tumor of probable Wolffian origin diagnosed during the staging evaluation of extranodal diffuse large B-cell lymphoma.


      Leuk Lymphoma. 2005 Jun;46(6):929-33.
    • Sevinc A, Buyukberber S, Camci C. Medical jargon: obstacle to effective communication between physicians and patients.


      Med Princ Pract. 2005 Jul-Aug;14(4):292.
    • Sevinc A, Buyukberber N, Camci C, Buyukberber S, Karsligil T. Thrombocytopenia in brucellosis: case report and literature review.


      J Natl Med Assoc. 2005 Feb;97(2):290-3.
    • Sevinc A, Buyukberber S, Camci C, Koruk M, Savas MC, Turk HM, Sari I, Buyukberber NM. Granulocytic sarcoma of the colon and leukemic infiltration of the liver in a patient presenting with hematochezia and jaundice.


      Digestion. 2004;69(4):262-5.
    • Erkilic S, Erbagci Z, Kocer NE, Bayazit YA, Camci C. Cutaneous involvement in Hodgkin’slymphoma: report of two cases.


      J Dermatol. 2004 Apr;31(4):330-4.
    • Bayazit YA, Buyukberber S, Sari I, Camci C, Ozer E, Sevinc A, Karakok M, Kanlikama M, Mumbuc S. Cyclo-oxygenase 2 expression in laryngeal squamous cell carcinoma and its clinical correlates.


      ORL J Otorhinolaryngol Relat Spec. 2004;66(2):65-9.
    • Sevinc A, Buyukberber S, Camci C. Cardiotoxic drugs in breast cancer. J


      J Natl Med Assoc. 2004 May;96(5):690-1.
    • Turk HM, Buyukberber S, Camci C, Sevinc A, Tuncozgur B, Sivrikoz C, Kervancioglu R, Sari I. Intralobar pulmonary sequestration in a patient with non-Hodgkin's lymphoma: a cause of confusion.


      Am J Hematol. 2004 Feb;75(2):89-91.
    • Camci C, Understanding Colon Cancer- Book Rewiev.


      Journal of the National Medical Association, 2004; 96(1):120.
    • Turk HM, Pekdemir H, Buyukberber S, Sevinc A, Camci C, Kocabas R, Tarakcioglu M, Buyukberber NM. Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid.


      Tumor Biology 2003; 24: 172-175.
    • Sevinc A, Camci C, Turk HM, Buyukberber S. How to Interpret Serum CA 125 Levels in Patients with Serosal Involvement?


      A Clinical Dilemma. Oncology. 2003;65(1):1-6
    • Camci C, Turk HM, Erkilic S, Buyukberbe S, Uner A, Ozsarac C. Early multimodal therapy in adult Wilms' tumor: case report.


      J Chemother. 2002 Oct;14(5):530-2.
    • Camci C, Turk HM, Erkilic S, Buyukberbe S, Uner A, Ozsarac C. Early multimodal therapy in adult Wilms' tumor: case report.


      J Chemother. 2002 Oct;14(5):530-2.
    • Camci C, Buyukberber S, Tarakcioglu M, Adam SM, Camci C, Turk HM, Buyukberber N, Balat O. The effect of continuous ambulatory peritoneal dialysis on serum CA-125 levels.


      Eur J Gynaecol Oncol. 2002;23(5):472-4.
    • Camci C, Balat O. Neoadjuvant chemotherapy in ovarian cancer.


      Eur J Gynaecol Oncol. 2002;23(5):437-41.
    • Camci C, Guney C, Balkan A, Buyukberber N, Buyukberber S, Kadayifci A, Kubar A. The prevalence of TT virus in cancer patients.


      New Microbiol. 2002 Oct;25(4):463-8
    • Turk HM, Camci C, Buyukberber S, Tuncozgur B, Sivrikoz C, Elbeyli L, Sari I. Superior vena cava syndrome caused by chemotherapy-induced fibrosis.


      J Chemother. 2002 Aug;14(4):417-9.
    • Turk HM, Sevinc A, Camci C, Cigli A, Buyukberber S, Savli H, Bayraktar N. Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus.


      Acta Diabetol. 2002 Sep;39(3):117-22.
    • Okan V, Araz M, Camci C, Aktaran S, Sahin A, Buyukberber S, Bakir K, Cakmak EA. Bernard-Soulier syndrome in a Turkish family.


      Int J Clin Pract. 2002 Sep;56(7):546-8.
    • Tarakcioglu M, Erbagci A, Cekmen M, Usalan C, Cicek H, Ozaslan J, Camci C. Acute effect of haemodialysis on serum markers of myocardial damage.


      Int J Clin Pract. 2002Jun;56(5):328-32.
    • Camci C, Turk HM, Buyukberber S, Karakok M, Koruk M, Beyazity Y, Inaloz HS. Colon carcinoma with synchronous subcutaneous and osseous metastasis: a case report


      J Dermatol. 2002 Jun;29(6):362-5.
    • Camci C, Sari R, Buyukberber S, Kutlu R, Sevinc A, Cokkeser Y. Non-invasive imaging methods before fine-needle aspiration in the diagnosis of cervical masses.


      Int J Clin Pract. 2002 Mar;56(2):147-8.
    • Balat O, Aydin A, Camci C, Kutlar I, Buyukberber S. Bilateral primary squamous cell carcinoma of the ovary: a case report of isolated metastasis to the lateral pelvic wall.


      Eur J Gynaecol Oncol. 2001;22(6):445-6.
    • Balat O, Aydin A, Kutlar I, Camci C. Ruptured granulosa cell tumor of the left ovary and mature cystic teratoma of the right ovary:a case report of unusual acute abdominal syndrome.


      EurJGynaecolOncol 2001;22(5):350-1.
    • Sari R, Camci C, Kutlu R, Totan Y, Sevinc A, Buyukberber S. The efficacy of acetazolamide on visual functions in a patient with choroid metastasis of breast carcinoma.


      Int J Clin Pract. 2001 Sep;55(7):488-90.
    • Camci C, Sari R, Sevinc A, Buyukberber S. Dacarbazine-induced carotid artery and deep venous thrombosis in a patient with leiomyosarcoma:


      case report. J Chemother. 2001 Apr;13(2):206-9.
    • Kadikoylu G, Ayhan M, Bolaman AZ, Sonmez HM, Camci C, Senturk T. Congenital dyserythropoietic anemia type 1 with positive acidified hemolysis test.


      Haema 2000; 3(4): 236-239.
    • Bolaman Z, Camci C, Sonmez HM, Kadikoylu G, Muftuoglu E. High dose methylprednisolone therapy before splenectomy for chronic idiopathic thrombocytopenic purpura.


      Haema 2000; 3(3): 180-184.
    • Sari R, Camci C, Sevinc A, Demirbilek O, Ertas E, Buyukberber S. The effect of abdominal surgery on serum CA-125 levels.


      Clin Exp Obstet Gynecol. 2000;27(3-4):244-5.
    • Sevinc A, Sari R, Camci C, Buyukberber S. A secondary interpretation is needed on serum CA 125 levels in case of serosal involvement.


      J R Soc Health. 2000 Dec;120(4):268-70.
    • Sonmez HM, Basak O, Camci C, Baltaci R, Karazeybek HS, Yazgan F, Ertin I, Celik SC. The epidemiology of elevated blood pressure as an estimate for hypertension in Aydin, Turkey.


      J Hum Hypertens. 1999 Jun;13(6):399-404.
    • Camci C, Paydas S, Sahin B, Cosar E. Malignant lymphoma with severe hypoglycemia.


      Eur JCancer 1996; 32A:2185.
    • Aykan NF, Yalçın Ş, Turhal NS, Özdoğan M, Demir G, Özkan M, Yaren A, Camcı C, et al. Epidemiology of colorectal cancer in Turkey: A cross-sectional disease registry study (A Turkish Oncology Group trial).


      Turkish Journal of Gastroenterology 2015; 26(2): 145-153.
    • Akkafa F, Arslan A, Öztuzcu S, Özardalı Hİ, Gökalp A, Özkara E, Bozdağ Z, Camcı C, Aytekin A. Meme kanserlerinde HtrA2 gen ifadesinin analizi.


      Harran Ünivrsitesi Tıp Fakültesi Dergisi 2014; 11(2): 1-10.
    • Ulaşlı M, Gürses S, Cengiz B, Öztuzcu S, Balakan O, Süner A, Göğebakan, B, İğci M, Balık A, Arslan A, Camcı C. Expression of PARP1 gene in breast cancer patients.


      Uluslararası Hematoloji-Onkoloji Dergisi 2013; 23(4): 213-218.
    • Camcı C, Kalender ME, Paydas S, Sevinc A, Zorludemir S, Suner A. Meme kanserinde Wilms Tümör 1 (WT1) protein ekpresyonunun prognostik önemi.


      Gaziantep Tıp Dergisi 2011; cilt 17, sayı 2: 67-72.
    • Kalender ME, Demiryürek Ş, Öztuzcu S, Kızılyer A, Demiryürek AT, Balakan O, Camcı C. ROCK 1 geni Lys222GLU ve Arg1262GLN polimorfizmleri ile meme kanseri arasındaki ilişkinin araştırılması.


      Gaziantep Tıp Dergisi 2011; cilt 17, sayı 2: 77-81.
    • Çömez G, Pehlivan Y, Sevinç A, Kervancıoğlu S, Sarıca MA, Tutar E, Camcı C. Maksiller sinüs tutulumlu ekstramedüller palasmositom: Genç bir olgu sunumu. Uluslararası Hematoloji-Onkoloji Dergisi 2008; 18(2): 112-115. Camcı C. Malign perikardiyal effüzyonlar.


      Türkiye Klinikleri Acil Tıp 2006; 2(33): 42-45.
    • Kalender ME, Sevinç A, Tutar E, Camcı C. Senkron renal hücreli karsinom ve meme medüller karsinom birlikteliği.


      Türk Hematoloji-Onkoloji Dergisi, 2005, 15: 90-93.
    • Sevinç A, Türk, HM, Camcı C. Topotekan.


      Hematoloji-Onkoloji Güncel Derleme Dergisi, 2004; 5(2): 95-104.
    • Camcı C, Sevinç A, Sarı R, Büyükberber S. Hemodiyaliz ve periton diyaliz hastalarında serum Protein C, Protein S ve Antitrombin III düzeyleri.


      Türkiye Tıp Dergisi (Dahili Tıp Bilimleri) 2001; 8(2): 51-55.
    • Camcı C, Paydaş S, Tanrıverdi K. Lösemilerde nm23-H1 ve nm23-H2 mRNA ekspresyonunun RT-PCR yöntemi ile incelenmesi.


      THOD (Türk Hematoloji-Onkoloji Dergisi) 2001; 11(1): 19-25.
    • Özbek E, Mızrak B, Özbek M, Camcı C. Mesane kanserinde inducible nitrit oksit ekspresyonu.


      THOD (Türk Hematoloji-Onkoloji Dergisi) 2001; 11(1): 25-31.
    • Camcı C, Büyükberber N, Büyükberber S, Harputluoğlu M, Ak G, Sarı R. Düşük riskli febril nötropenide antibiyotik protokollerinin karşılaştırılması.


      Türkiye Tıp Dergisi(Dahili Tıp Bilimleri) 2001; 8(1): 23-27.
    • Camcı C, Sarı R, Sevinç A, Büyükberber S. Temporary diffuse hyperpigmentation induced by weekly 5-Fluorouracil and Leucovorin chemotherapy.


      THOD (Türk Hematoloji-Onkoloji Dergisi) 2001; 11(2): 98-99
    • Kadıköylü G, Ayhan M, Bolaman Z, Sönmez HM, Camcı C, Şentürk T. Asit hemoliz testi pozitif tip 1 kongenital diseritropoetik anemili bir olgu.


      Türkiye Tıp Dergisi Dahili Bileimler 2001; 8(2): 79-82.
    • Camcı C, Seyrek E, Sönmez H.M, Çiçek C, Özgel N, Bolaman Z. İki olgu nedeniyle feokromositoma.


      Van Tıp Dergisi 2001; 8(1): 27-32.
    • Camcı C, Yaşa MH. Helicobacter pylori ve mide kanseri.


      Kocatepe Tıp Dergisi 2000; 1(2): 65-70.
    • Camcı C, Bolaman Z, Sönmez HM, Öge A, Çiçek C, Yavaşoğlu İ. Gebeliğe bağlı Coombs negatif hemolitik anemi.


      ADÜ School of Medicine Dergisi 2000; 1(1): 43-45.
    • Özet A, Arpacı F, Öztürk B, Camcı C, Safalı M, Kömürcü Ş, Güleç B, Yılmaz İ, Ayta H, Yavuz AA, Pak Y, Yücel İ, Yalçın A. Results of high dose chemotherapy (HDC) and autologous peripheral blood stem cell transplantation (APBSCT) in 45 patients with breast cancer.


      Turkish Journal of Cancer 2000; 30(4): 139-147.
    • Camcı C, Paydaş S, Zorludumir S, Hazar B, Şahin B. Immunohisto-chemical analysis of prostate spesific antigen in breast cancer and correlation with clinical parameters.


      THOD (Türk Hematoloji-Onkoloji Dergisi) 2000; 10(3): 130-137.
    • Yaşa MH, Bektaş A, Akbulut H, Camcı C, Örmeci N. Mide karsinomları ve prekanseröz mide lezyonlarının DNA analizi ve DNA ploidi ile ilişkisi.


      Türkiye Klinikleri Gastroenterohepatoloji 2000; 11(3): 115-122.
    • Camcı C, Paydaş S, Şahin B, Hazar B. A single center randomized study comparing the efficacy of Ciprofloxacin+Amikacin vs Imipenem/Cilastatin in febrile neutropenic patients.


      Annals of Medical Sciences 2000; 9(2): 48-50.
    • Kadıköylü G, Camcı C, Sönmez HM, Öge A, Bolaman Z, Şentürk T. Tip-II diabette asemptomatik kolelitiazis sıklığı.


      ADÜ School of Medicine Dergisi 2000; 1(1): 17-20.
    • Sönmez HM, Başak O, Camcı C, Baltacı R, Karazeybek HŞ, Yazgan F, Ertin İ, Çelik SÇ. Aydın yöresinde resmi sağlık kurumlarının hipertansiyon tanısı ve sağaltımındaki etkinliği.


      Ç.Ü.School of Medicine Dergisi, 2000; 25: 69-78.
    • Camcı C, Bolaman Z, Sönmez HM, Öge A, Çiçek C, Yavaşoğlu İ. Gebeliğe bağlı Coombs negatif hemolitik anemi.


      ADÜ School of Medicine Dergisi 2000; 1(1): 43-45.
    • Sönmez HM, Başak O, Camcı C, Baltacı R, Karazeybek HŞ, Yazgan F. Aydın yöresinde on yedi yaş üstü kitlede sigara içimi ve hipertansiyonla birlikteliği.


      Ege Tıp Dergisi 2000; 39(2): 105-111.
    • Bolaman Z, Camcı C, Sönmez HM, Öge A, Kadıköylü G, Tuncer G. Transfüzyonla ilgili akut akciğer hasasında yüksek doz intravenöz metilprednizolon tedavisi.


      Adnan Menderes Üniveristesi Tıp Fakültesi Dergisi 2000; 1(2): 43-46.
    • Akyol A, Bölükbaşı O, Genel H, Camcı C. Trousseau Sendromu.


      Fırat Tıp Dergisi 1999; 1(7):519-521.
    • Camcı C. Bir tümör süpresör gen:


      nm23. Arşiv 1999; 8(1):1-22.
    • Camcı C, Tanrıverdi S, Paydaş S, Özcan K. Blastocystis Hominis in a leukemia patient.


      Annals of Medical Sciences 1999; 8(1): 70-71.
    • Şahna K, Camcı C, Şirin S, Tunç ŞE, Gölbaşı Z, Pürsünlerli G. Sol ventrikül diyastolik doluşu üzerine hemodializin etkisinin doppler ekokardiyografi ile değerlendirilmesi.


      .Medical Network Cardiology 1996; 3(4):350-358.
    • Özet G, Yılmaz Ö, Camcı C, Tülce E, Özet A, Esen M, Pürsünlerli G. Q ve Non-Q myokart infarktüslerinde risk faktörleri, klinik seyir ve prognoz.


      Yeni Tıp Dergisi 1994; 11(4):8-13.
    • Yılmaz Ö, Özet G, Camcı C. Kronik anemili hastalarda sol ventrikül sistolik ve diyastolik fonksiyonlarının ekokardiyografik olarak değerlendirilmesi.


      Journal of Turgut Özal Medical Center 1994; 1(2):122-125.
    • Şahna K, Navruz MZ, Camcı C, Şirin S, Tunç ŞE, Pürsünlerli G. Genç yaş akut myokart infarktüslerinde Apolipoprotein A1 ve Apolipoprotein B’nin tayini.


      Türkiye Tıp Dergisi 1994; 1(1):23-27.
    • Yılmaz Ö, Camcı C, Şahna K, Şirin S, Navruz MZ, Tülce E, Pürsünlerli G. Yatak başında geçici pacemaker uygulaması.


      T. Klin. Tıp Bilimleri 1993; 13:135-136.
    • Navruz MZ, Yılmaz Ö, Camcı C, Tülce E, Pürsünlerli G. Pulmoner arter sistolik basıncının değerlendirilmesinde pulmoner ve triküspit kapak akımlarının pulsed doppler ekokardiyografi ile incelenmesi.


      T. Klin. Kardiyoloji 1993; 3:206-211.
    • Yılmaz Ö, Navruz MZ, Camcı C, Özet G, Pürsünlerli G. Akut myokart infarktüsünde sağ ventrikül fonksiyonlarının pulsed-doppler ekokardiyografi ile değerlendirilmesi.


      T. Klin. Kardiyoloji 1993; 6:22-26.
    • Yılmaz Ö, Navruz MZ, Camcı C, Pürsünlerli G. Hafif ve orta dereceli hipertansiyonlu hastalarda sol ventrikül fonksiyonlarının ekokardiyografik olarak incelenmesi.


      Sağlık Dergisi (Sağlık Bakanlığı) 1991; 63(1):5-11.
    • Navruz MZ, Tülce E, Şahna K, Camcı C, Esen M, Pürsünlerli G. Akut myokart infarktüsünde serum myoglobin düzeyi.


      Sağlık Dergisi (Sağlık Bakanlığı) 1990; 62(2):47-50.
    • Uluslararası kongrelerde sunulmuş ve bildiri kitabında yayınlanmış olan araştırmalar:


      21 adet
    • Ulusal kongrelerde sunulmuş ve bildiri kitabında yayınlanmış olan araştırmalar:


      96 adet
    • YÖNETİLEN TEZLER: İç Hastalıkları Anabilim Dalı’nda 4, Tıbbi Onkoloji Bilim Dalı’nda


      5 adet
    • KONUŞMACI OLARAK KATILDIĞIM KONGRE, SEMPOZYUM VE TOPLANTILAR:


      46 adet
    • Primer Araştırmacı (Principal Investigator) olduğum çalışmalar:


      13 adet ulusal ve uluslararası düzeyde yürütülmüş ve tamamlanmış proje
    • Gaziantep Üniversitesi BAP (Bilimsel Araştırma Projeleri) kapsamında yürütücü/yardımcı araştırmacı olduğum projeler:


      11 adet proje tamamlanmıştır.
    • A8. Asik M, Sen C, Taser OF, Alturfan AK, Sozen YV. “Discoid lateral meniscus: diagnosis and results of arthroscopic treatment”,


      Knee Surg Sports Traumatol Arthrosc, 11(2), 99-104 (2003)
    • A9. Sen C, Kocaoglu M, Eralp L. “The advantages of circular external fixation used in high tibial osteotomy (average 6 years follow-up)”,


      Knee Surg Sports Traumatol Arthrosc, 11(3), 139-44 (2003)
    • 1.YÜRÜTTÜĞÜM PROJELER a. Primer Araştırmacı (Principal Investigator) olduğum çalışmalar:


      13 adet ulusal ve uluslararası düzeyde yürütülmüş ve tamamlanmış proje
    • 1.YÜRÜTTÜĞÜM PROJELER b. Gaziantep Üniversitesi BAP (Bilimsel Araştırma Projeleri) kapsamında yürütücü/yardımcı araştırmacı olduğum projeler:


Bht Clinic
Merhaba, size nasıl yardımcı olabiliriz?